GlassScriptPhysician profile
Michael W Parra
NPI 1770679771
$4,818.45
in general payments reported to CMS, 2019-2025
18 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $199 · 2021: $214 · 2022: $442 · 2023: $143 · 2024: $570 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080 · Travel and Lodging: $660 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.79 |
| Travel and Lodging | $660.10 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,234.62 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Applied Medical Resources Corporation | $863.52 | 2019 | |
| Ethicon US, LLC | $303.68 | 2020-2024 | Vistaseal |
| Acera Surgical, INC. | $228.03 | 2024-2025 | Restrata Wound Matrix |
| Davol INC. | $204.02 | 2019-2024 | Phasix Mesh |
| Csl Behring | $170.14 | 2020-2024 | Kcentra |
| Aroa Biosurgery Incorporated | $122.22 | 2024 | |
| Allergan, INC. | $120.74 | 2019 | |
| Medical Device Business Services, INC. | $118.34 | 2019 | |
| Kerecis Limited | $105.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Conmed Corporation | $80.00 | 2019 | |
| Smith+Nephew, INC. | $70.75 | 2022-2023 | Oasis Micro, Grafix Pl, Stravix |
| Innocoll Pharmaceuticals Limited | $50.79 | 2022 | |
| Astellas Pharma US INC | $41.29 | 2022-2023 | Myrbetriq |
| Covidien LP | $31.53 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $30.00 | 2020 | |
| Humacyte Global, INC. | $27.38 | 2025 | Symvess |
| Ambu INC. | $15.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Parra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.